Definition/General

Introduction:
-Non-caseating lymphadenitis is characterized by epithelioid granulomas without central necrosis, representing a chronic immune response to various stimuli
-Sarcoidosis is the prototype condition but multiple other causes exist
-The absence of caseous necrosis distinguishes it from tuberculous lymphadenitis and represents different pathophysiological mechanisms of granuloma formation.
Origin:
-Results from chronic antigenic stimulation with contained immune response
-Sarcoidosis (most common cause, unknown etiology)
-Berylliosis (occupational exposure to beryllium)
-Hypersensitivity pneumonitis (organic dust exposure)
-Drug-induced granulomatous reactions
-Autoimmune conditions (Crohn disease, primary biliary cirrhosis)
-Foreign body reactions (silica, tattoo pigments).
Classification:
-Classified by underlying etiology: Sarcoidosis (systemic granulomatous disease)
-Occupational lung diseases (berylliosis, silicosis)
-Drug-induced (methotrexate, TNF-α inhibitors)
-Autoimmune-associated
-Infectious (brucellosis, some fungal infections)
-Malignancy-associated (sarcoid-like reactions)
-Idiopathic non-caseating granulomatous lymphadenitis.
Epidemiology:
-Variable epidemiology depending on underlying cause
-Sarcoidosis: peak in 3rd-4th decades, higher in Scandinavians and African Americans
-Berylliosis: occupational exposure history
-Drug-induced: related to specific medications
-Geographic clustering for some causes
-Lower prevalence in Indian population compared to Western countries.

Clinical Features

Presentation:
-Bilateral hilar lymphadenopathy (classic sarcoidosis presentation)
-Asymptomatic lymphadenopathy common (incidental finding)
-Peripheral lymphadenopathy in 25-30% of cases
-Löfgren syndrome (acute sarcoidosis with erythema nodosum, arthritis)
-Systemic symptoms variable
-Multi-organ involvement possible
-Symmetric, bilateral distribution.
Symptoms:
-Asymptomatic in 30-50% of patients
-Respiratory symptoms: dry cough, dyspnea, chest pain
-Constitutional symptoms: fever, weight loss, fatigue
-Skin manifestations: erythema nodosum, lupus pernio, plaques
-Ocular symptoms: uveitis, conjunctival nodules
-Neurological symptoms: cranial nerve palsies
-Cardiac symptoms: arrhythmias (rare but serious).
Risk Factors:
-Genetic predisposition (HLA-DRB1, HLA-DQB1 associations)
-Environmental exposures (organic dusts, metals)
-Occupational exposures (beryllium, silica)
-Geographic location (higher prevalence areas)
-Family history of sarcoidosis
-Female gender (slight predominance)
-Healthcare worker (some studies suggest increased risk).
Screening:
-Chest X-ray (bilateral hilar lymphadenopathy pathognomonic)
-High-resolution CT for detailed assessment
-Serum ACE levels (elevated in 60% of active sarcoidosis)
-Serum calcium and 24-hour urine calcium
-Pulmonary function tests
-Ophthalmologic examination
-Tissue biopsy for histological confirmation
-Exclusion of infections (TB, fungi).

Master Non-Caseating Lymphadenitis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Enlarged lymph nodes with firm, rubbery consistency
-Cut surface shows gray-white homogeneous appearance
-Multiple small nodules corresponding to granulomas
-No necrosis or caseation
-Preserved capsule without adherence
-Bilateral involvement common
-Fibrotic changes in chronic cases.
Characteristics:
-Firm consistency due to granulomatous infiltration
-Homogeneous gray-white cut surface
-No softening or fluctuation
-Discrete nodular pattern may be visible
-No calcification typically
-Preserved architecture grossly
-Multiple lymph nodes similarly affected.
Size Location:
-Hilar lymph nodes most commonly affected (90% in sarcoidosis)
-Bilateral symmetric involvement characteristic
-Mediastinal lymph nodes (paratracheal, subcarinal)
-Peripheral lymph nodes in 25-30% of cases
-Size ranges from 1-5 cm typically
-Retroperitoneal involvement less common.
Multifocality:
-Bilateral hilar involvement pathognomonic (potato nodes)
-Symmetric distribution pattern
-Multiple lymph node stations involved
-Systemic disease with multi-organ involvement
-Peripheral lymphadenopathy may accompany hilar disease
-Spontaneous regression possible.

Microscopic Description

Histological Features:
-Well-formed epithelioid granulomas without central necrosis
-Epithelioid cells with abundant eosinophilic cytoplasm
-Multinucleated giant cells (Langhans and foreign body types)
-Schaumann bodies and asteroid bodies in giant cells
-Lymphocytes and plasma cells at periphery
-Preserved lymph node architecture
-Fibrosis in chronic cases.
Cellular Characteristics:
-Epithelioid cells (activated macrophages) predominant
-Multinucleated giant cells with inclusion bodies
-Schaumann bodies (laminated, basophilic inclusions)
-Asteroid bodies (star-shaped, eosinophilic inclusions)
-Chronic inflammatory cells at granuloma margins
-Absence of neutrophils
-No necrosis or caseation.
Architectural Patterns:
-Discrete, well-circumscribed granulomas
-Interfollicular and paracortical location
-Preserved follicular structures between granulomas
-No architectural effacement in early stages
-Granulomas may coalesce in advanced cases
-Capsular involvement possible
-Fibrotic replacement in chronic stages.
Grading Criteria:
-No standard grading system for non-caseating granulomas
-Granuloma density and distribution
-Degree of giant cell formation
-Inclusion body content (Schaumann, asteroid bodies)
-Associated fibrosis extent
-Activity assessment (epithelioid cell morphology)
-Architectural preservation vs distortion.

Immunohistochemistry

Positive Markers:
-CD68 positive in epithelioid cells and giant cells
-CD163 positive in M2 macrophages
-Lysozyme positive in epithelioid cells
-CD3 highlights T-lymphocytes around granulomas
-CD20 shows preserved B-cell follicles
-S-100 may be positive in some giant cells
-Smooth muscle actin may be positive in epithelioid cells.
Negative Markers:
-CD1a and Langerin negative (excludes Langerhans cell histiocytosis)
-CD30 negative (excludes lymphoma)
-Cytokeratin negative in epithelioid cells
-Melanoma markers negative
-CD34 negative in epithelioid cells
-ALK-1 negative
-Mycobacterial markers negative.
Diagnostic Utility:
-Limited utility for determining specific etiology
-CD68 confirmation of histiocytic nature
-Negative infectious stains (AFB, GMS, PAS) essential
-Polarized light examination for foreign material
-ACE levels and calcium metabolism more helpful for sarcoidosis
-Beryllium lymphocyte proliferation test for berylliosis.
Molecular Subtypes:
-No molecular subtypes but genetic associations recognized
-HLA-DRB1*03, HLA-DQB1*02 (Löfgren syndrome)
-BTNL2 gene variants (sarcoidosis susceptibility)
-ANXA11 gene polymorphisms
-Environmental trigger variations may influence presentation
-Familial clustering suggests genetic component.

Molecular/Genetic

Genetic Mutations:
-No specific mutations but genetic susceptibility loci identified
-HLA associations (multiple alleles)
-BTNL2, ANXA11, FAM177B gene variants
-NOTCH4, TNF-α promoter polymorphisms
-Complement component variants
-Vitamin D pathway gene polymorphisms
-No oncogene activation or tumor suppressor loss.
Molecular Markers:
-Elevated serum ACE (angiotensin-converting enzyme)
-Hypercalciuria and hypercalcemia
-Elevated 1,25-dihydroxyvitamin D3
-Soluble IL-2 receptor (sIL-2R)
-Th1 cytokines (IFN-γ, IL-2, TNF-α)
-Lysozyme levels increased
-Complement activation products.
Prognostic Significance:
-Variable prognosis depending on underlying cause and presentation
-Löfgren syndrome: excellent prognosis (90% spontaneous remission)
-Chronic progressive sarcoidosis: may lead to organ dysfunction
-Pulmonary fibrosis: serious complication
-Cardiac sarcoidosis: potentially fatal arrhythmias
-Neurosarcoidosis: significant morbidity
-Overall mortality: 1-5% of sarcoidosis cases.
Therapeutic Targets:
-Corticosteroids (first-line for symptomatic disease)
-Methotrexate as steroid-sparing agent
-Azathioprine, mycophenolate for maintenance
-Hydroxychloroquine (skin involvement, hypercalcemia)
-TNF-α inhibitors (refractory cases)
-Rituximab for severe cases
-Observation for asymptomatic disease.

Differential Diagnosis

Similar Entities:
-Tuberculosis (caseating granulomas)
-Histoplasmosis (organisms in macrophages)
-Berylliosis (occupational exposure)
-Hypersensitivity pneumonitis (poorly formed granulomas)
-Crohn disease (GI involvement)
-Primary biliary cirrhosis (liver involvement)
-Foreign body reaction (polarizable material).
Distinguishing Features:
-Non-caseating lymphadenitis: well-formed granulomas without necrosis, bilateral hilar lymphadenopathy, elevated ACE
-Tuberculosis: caseating granulomas, asymmetric involvement, positive AFB
-Histoplasmosis: organisms visible, endemic areas, GMS positive
-Berylliosis: occupational history, beryllium test positive
-Hypersensitivity pneumonitis: poorly formed granulomas, exposure history.
Diagnostic Challenges:
-Exclusion diagnosis requiring negative infectious workup
-Sarcoid-like reactions in malignancy
-Drug-induced granulomas require medication history
-Occupational causes need exposure assessment
-Overlap with other autoimmune conditions
-Atypical presentations in different organs
-Clinical correlation essential.
Rare Variants:
-Löfgren syndrome (acute sarcoidosis with excellent prognosis)
-Heerfordt syndrome (parotid enlargement, uveitis, fever, facial palsy)
-Blau syndrome (familial granulomatous disease)
-Cardiac sarcoidosis (isolated cardiac involvement)
-Neurosarcoidosis (CNS granulomas)
-Osseous sarcoidosis (bone involvement)
-Cutaneous sarcoidosis variants.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Lymph node biopsy from [hilar/peripheral] location, measuring [X.X] cm in greatest dimension

Diagnosis

Non-caseating granulomatous lymphadenitis, consistent with sarcoidosis

Pattern Classification

Pattern: [well-formed non-caseating granulomas], distribution: [interfollicular/diffuse], activity: [active/chronic]

Histological Features

Shows [well-formed epithelioid granulomas] with [giant cells and inclusion bodies] without necrosis

Size and Distribution

Size: [X.X] cm, granulomas: [discrete/coalescent], architecture: [preserved/minimally distorted]

Granuloma Characteristics

Granulomas contain [epithelioid cells/Langhans giants/Schaumann bodies/asteroid bodies] without [necrosis/caseation]

Special Studies

Special stains: AFB [negative], GMS [negative], PAS [negative for organisms]

Polarized light: [negative for foreign material]

Clinical correlation: [bilateral hilar lymphadenopathy/ACE levels/calcium studies]

Final Diagnosis

Non-caseating granulomatous lymphadenitis, most consistent with sarcoidosis, clinical correlation recommended